Thang Ho

A model-based clinically-relevant chemotherapy scheduling algorithm for anticancer agents

Thang Ho, 2014 .

A model of neutrophil dynamics in response to inflammatory and cancer chemotherapy challenges

Gilles Clermont, Robert S. Parker, Thang Ho, 2013, Comput. Chem. Eng..

CX-2029, a PROBODY drug conjugate targeting CD71 (transferrin receptor): Results from a first-in-human study (PROCLAIM-CX-2029) in patients (Pts) with advanced cancer.

A. El-Khoueiry, H. Mamdani, A. Spira, 2020 .